Trials / Completed
CompletedNCT01668537
A Phase II Trial to Compare a Liquid-frozen and a Freeze-dried Formulation of IMVAMUNE (MVA-BN®) Smallpox Vaccine in Vaccinia-naïve Healthy Subjects
A Randomized, Double-blind, Multicenter Phase II Trial to Compare the Immunogenicity and Safety of a Liquid-frozen and a Freeze-dried Formulation of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Vaccinia-naïve Healthy Subjects
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 651 (actual)
- Sponsor
- Bavarian Nordic · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A randomized, double-blind, multicenter Phase II trial to compare the immunogenicity and safety of a liquid-frozen and a freeze-dried formulation of IMVAMUNE (MVA-BN®) smallpox vaccine in vaccinia-naïve healthy subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | LF formulation of IMVAMUNE® | |
| BIOLOGICAL | FD formulation of IMVAMUNE® |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2014-01-01
- Completion
- 2014-06-01
- First posted
- 2012-08-20
- Last updated
- 2020-10-12
- Results posted
- 2020-10-12
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01668537. Inclusion in this directory is not an endorsement.